Attachment C -- 30 day notice 12-06-2007

Federal Register / Vol. 72, No. 234 / Thursday, December 6, 2007 / Notices

68885

Therefore the estimate of total burden of
the survey is 663 hours.

EXHIBIT 1.—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Number of
respondents

Form name

Hours per
response

Total burden
hours

Mail survey with mail and telephone follow up ................................

1,987

1

20/60

663

Total ..........................................................................................

1,987

1

20/60

663

EXHIBIT 2.—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents

Form name

Total burden
hours

Average hourly
wage rate*

Total cost
burden

Mail survey with mail and telephone follow up ................................

1,987

663

$20.00

$13,260

Total ..........................................................................................

1,987

663

20.00

13,260

* Based upon the average wages, ‘‘National Compensation Survey: Occupational Wages in the United States, June 2006,’’ U.S. Department of
Labor, Bureau of Labor Statistics. (http://www.bls.gov/ncs/home.htm. Last viewed August 27, 2007.)

Estimated Annual Costs to the Federal
Government
The total cost to the Government for
developing this survey is approximately
$880,000. The contracted costs include
approximately $600,000 for survey
development, $110,000 for data
collection and $90,000 for analysis of
field test results. Total costs also
include $80,000 in AHRQ staff costs.

mstockstill on PROD1PC66 with NOTICES

Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s Information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ healthcare research and
healthcare dissemination functions,
including whether the information will
have practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
the hours and costs) of the proposed
collection of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.

VerDate Aug<31>2005

18:57 Dec 05, 2007

Jkt 214001

Dated: November 29, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–5949 Filed 12–5–07; 8:45 am]
BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:

SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) allow the renewal of the
generic information collection project:
‘‘Questionnaire and Data Collection
Testing, Evaluation, and Research for
the Agency for Healthcare Research and
Quality.’’ In accordance with the
Paperwork Reduction Act of 1995,
Public Law 104–13 (44 U.S.C.
3506(c)(2)(A)), AHRQ invites the public
to comment on this proposed
information collection.
This proposed information collection
was previously published in the Federal
Register on August 15, 2007 and
allowed 60 days for public comment. No
comments were received. A 30-day
Federal Register notice was published
on October 19, 2007 to allow an
additional 30 days for public comment.
No comments were received. However,

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

changes to the estimated annual
respondent burden hours and the
methodologies that will be used for the
data collection require an additional 30
days for public comment.
DATES: Comments on this notice must be
received by January 7, 2008.
ADDRESSES: Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by
e-mail at
[email protected]
(attention: AHRQ’s desk officer).
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from AHRQ’s Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ, Reports
Clearance Officer, (301) 427-1477.
SUPPLEMENTARY INFORMATION:
Proposed Project
‘‘Questionnaire and Data Collection
Testing, Evaluation, and Research for
the Agency for Healthcare Research and
Quality.’’
AHRQ plans to employ the latest
techniques to improve its current data
collections by developing new surveys,
or information collection tools and
methods, and by revising existing
collections in anticipation of, or in
response to, changes in the healthcare
field, for a three-year period. The
clearance request is limited to research
on information collection tools and
methods, and related reports and does
not extend to the collection of data for
public release.
A generic clearance for this work
allows AHRQ to draft and test

E:\FR\FM\06DEN1.SGM

06DEN1

68886

Federal Register / Vol. 72, No. 234 / Thursday, December 6, 2007 / Notices

information collection tools and
methods more quickly, thereby
managing project time more efficiently
and improving the quality of the
methodological data the agency collects.
In some instances the ability to pretest/pilot-test information collection
surveys, tool and methods, in
anticipation of work, or early in a
project, may result in the decision not
to proceed with particular survey
activities. This would save both public
and private resources and effectively
eliminate or reduce respondent burden.
Many of the tools AHRQ develops are
made available to users in the private
sector. The health care environment
changes rapidly and requires a quick
response from the agency to provide
appropriately refined tools. A generic

clearance for this methodological work
will facilitate the agency’s timely
development of information collection
tools and methods suitable for use in
changing conditions.
It is particularly important to refine
AHRQ’s tools because they have a
widespread impact. This tools are
frequently made available to help the
private sector to improve health care
quality by enabling the gathering of
useful data for analysis. They are also
used to provide information about
health care quality to consumers and
purchasers so that they can make
marketplace choices to influence and
improve health care quality. The current
clearance will expire January 31, 2008.
This is a request for a generic approval

from OMB to test information collection
instruments and methods over the next
three years.
Methods of Collection
Participation in the testing of
information collection tools and
methods will be fully voluntary and
non-participation will have no affect on
eligibility for, or receipt of, future
AHRQ health services research support
or on future opportunities to participate
in research or to obtain information
research results. Specific estimation
procedures, when used, will be
described when we notify OMB as to
actual studies conducted under the
clearance.
Estimated Annual Respondent Burden

EXHIBIT 1.—ESTIMATED ANNUALIZED BURDEN HOURS
Type of information
collection

Number of
responses per
respondent

Number of
respondents

Hours per
response

Total burden
hours

Mail/e-mail* ......................................................................................
Telephone ........................................................................................
Web-based .......................................................................................
Focus Groups ..................................................................................
In-person ..........................................................................................
Automated** .....................................................................................
Cognitive Lab Experiments ..............................................................

8,000
200
2,000
100
200
500
200

1
1
1
1
1
1
1

20/60
40/60
10/60
2.0
1.0
1.0
1.5

2,667
134
334
200
200
500

Totals ........................................................................................

11,200

na

na

4,335

* May include telephone non-response follow-up in which case the burden will not change.
** May include testing of database software, CAPI software or other automated technologies.

EXHIBIT 2.—ESTIMATED ANNUALIZED COST BURDEN
Type of information
collection

Number of
respondents

Total burden
hours

Average hourly
wage rate*

Total cost
burden

Mail/e-mail* ......................................................................................
Telephone ........................................................................................
Web-based .......................................................................................
Focus Groups ..................................................................................
In-person ..........................................................................................
Automated** .....................................................................................
Cognitive Lab Experiments ..............................................................

8,000
200
2,000
100
200
500
200

2,667
134
334
200
200
500
300

$30.00
30.00
30.00
30.00
30.00
30.00
30.00

$80,010
4,020
10,020
6,000
6,000
15,000
9,000

Totals ........................................................................................

11,200

4,335

30.00

130,050

* May include telephone non-response follow-up in which case the burden will not change.
** May include testing of database software, CAPI software or other automated technologies.

mstockstill on PROD1PC66 with NOTICES

This information collection will not
impose a cost burden on the
respondents beyond that associated
with their time to provide the required
data. There will be no additional costs
for capital equipment, software,
computer services, etc.
Estimated Annual Costs to the Federal
Government
Information collections conducted
under this generic clearance will in
some cases be carried out under
contract. Assuming four data collections
per year (either mail/e-mail, telephone,

VerDate Aug<31>2005

18:57 Dec 05, 2007

Jkt 214001

web-based or in-person) at an average
cost of $150,000 each, and two focus
groups, automated data collections or
lab experiments at an average cost of
$20,000 each, total contract costs could
be $640,000 per year.
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of

PO 00000

Frm 00030

Fmt 4703

Sfmt 4703

AHRQ health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.

E:\FR\FM\06DEN1.SGM

06DEN1

68887

Federal Register / Vol. 72, No. 234 / Thursday, December 6, 2007 / Notices
mail to [email protected]. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.

Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.

Proposed Project

Dated: November 29, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–5950 Filed 12–05–07; 8:45 am]

Gonococcal Isolate Surveillance
Project (GISP)—Revision—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Background and Brief Description
CDC is requesting a 3-year revision
with change for this project. The
objectives of GISP are to monitor trends
in antimicrobial susceptibility of strains
of Neisseria gonorrhoeae in the U.S. and
characterize resistant isolates. GISP
provides critical surveillance for
antimicrobial resistance, allowing for
informed treatment recommendations.
This project began in 1986 as a
voluntary surveillance project and has
involved 5 regional laboratories and 30
publicly-funded, sexually transmitted
disease (STD) clinics around the
country. The STD clinics submit up to
25 gonococcal isolates per month to the
regional laboratories, which measure

Centers for Disease Control and
Prevention
[30Day–08–0307]

Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an e-

susceptibility to a panel of antibiotics.
Limited demographic and clinical
information corresponding to the
isolates are submitted directly by the
STD clinics to CDC.
During 1986–2006, GISP has
demonstrated the ability to effectively
achieve its objectives. The emergence of
resistance in the United States to
penicillin, tetracyclines, and now
fluoroquinolones was identified through
GISP and makes ongoing surveillance
critical. Increased prevalence of
fluoroquinolone-resistant N.
gonorrhoeae (QRNG) as seen in GISP
data has prompted the CDC to update
the treatment recommendations for
gonorrhea in the CDC’s Sexually
Transmitted Diseases Treatment
Guidelines, 2006 and to release an
MMWR article stating the CDC no
longer recommends fluoroquinolones
for treatment of gonococcal infections
(CDC, MMWR, Vol.56, No.14, 332–336).
Respondents are paid by Federal funds
through the CDC Comprehensive STD
Prevention Systems, Prevention of STDRelated Infertility, and Syphilis
Elimination Grant (CSPS), for their
participation in GISP network. The
estimated annualized burden for this
data collection is 8,628 hours.

ESTIMATED ANNUALIZED BURDEN HOURS
No. of responses per respondent

Avg. burden
per response
(in hours)

Form name

Clinic ....................................................................
Laboratory ............................................................

Form 1 .................................................
Form 2 .................................................
Form 3 .................................................

30
5
5

240
1,452
48

11/60
1
12/60

Total ..............................................................

..............................................................

40

..........................

..........................

Dated: November 28, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer.
[FR Doc. E7–23633 Filed 12–5–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–08–0263]

mstockstill on PROD1PC66 with NOTICES

No. of
respondents

Type of respondent

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the

VerDate Aug<31>2005

18:57 Dec 05, 2007

Jkt 214001

Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be

PO 00000

Frm 00031

Fmt 4703

Sfmt 4703

collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Requirements for a Special Permit to
Import Cynomolgus, African Green, or
Rhesus Monkeys into the United
States—Extension—National Center for
Preparedness, Detection, and Control of
Infectious Diseases (NCPDCID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting OMB approval to
continue its data collection,
‘‘Requirements for a Special Permit to

E:\FR\FM\06DEN1.SGM

06DEN1